If this PR means that a new peer review article for the flu is forthcoming then that is EXCELLENT news! That peer review could/would then be followed up by additional peer review articles for HIV, Herpes, and all other corona viruses to show the broad spectrum capabilities of Brilacidin and that is even more EXCELLENT. This should shake the world of virologists to the core!
What I meant to imply was that the importance of this PR IMO is whether further peer review articles are to be expected and, if so, then the data for the flu at this time must be of the same caliber as that shown against CV19 IMO - based on RBL wanting to put out a peer review article.
(7)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links